Jupiter Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.79M	Sell	274,419 -115,949	-30%	-$2.76M	0.04%	319
2025 Q4	$9.11M	Sell	390,368 -10,723	-3%	-$239K	0.07%	226
2025 Q3	$7.9M	Sell	401,091 -116,575	-23%	-$2.4M	0.07%	240
2025 Q2	$11.2M	Buy	517,666 +29,079	+6%	+$686K	0.09%	222
2025 Q1	$11.8M	Buy	488,587 +6,600	+1%	+$149K	0.11%	208
2024 Q4	$10.1M	Sell	481,987 -217,957	-31%	-$4.68M	0.1%	226
2024 Q3	$13.9M	Sell	699,944 -41,731	-6%	-$774K	0.12%	197
2024 Q2	$11.5M	Sell	741,675 -67,685	-8%	-$1.05M	0.11%	194
2024 Q1	$12.9M	Sell	809,360 -34,571	-4%	-$521K	0.12%	196
2023 Q4	$14.2M	Sell	843,931 -53,115	-6%	-$726K	0.14%	181
2023 Q3	$10.5M	Buy	897,046 +350,184	+64%	+$4.68M	0.12%	197
2023 Q2	$7.34M	Sell	546,862 -876,722	-62%	-$12.6M	0.08%	243
2023 Q1	$23.6M	Buy	1,423,584 +1,376,339	+2,913%	+$22.7M	0.33%	97
2022 Q4	$878K	Buy	47,245 +879	+2%	+$13.5K	0.01%	376
2022 Q3	$595K	Buy	46,366 +15,679	+51%	+$186K	0.01%	423
2022 Q2	$215K	Buy	+30,687	New	+$225K	﹤0.01%	549